This analysis showed that baseline plasma APOC3 levels associate with CVD risk more strongly in individuals with type 2 diabetes than in those with impaired fasting glucose or without diabetes (Table 1, Extended Data Fig. 1a). This evidence concerns the gene APOC3 and type 2 diabetes mellitus.